| abstract |
Compounds having the structure of Formula I, or pharmaceutically acceptable salts, tautomers or stereoisomers thereof (wherein R 1 , R 2 , R 3 , R 11a , R 11b , R 11c , R 11d And X are as defined herein). In the use of such compounds, modulation of androgen receptor activity, diagnostic imaging agents and medicaments for cancer, and methods for treating a subject in need thereof, including prostate cancer, are also provided. In some embodiments, certain compounds disclosed herein are useful for imaging of the prostate. |